The World Health Organization’s Product Development for Vaccines Advisory Committee yesterday selected Biological E as a recipient of mRNA technology from the WHO technology transfer hub.
MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial.
Drug maker Lupin on Thursday told, its New Jersey facility has received 13 observations from the US drug regulator.
In the coming days curative therapies will change the face of the healthcare system.
HealthQuad, an India-focused healthcare venture capital firm, has raised $162 million in the final close of its second fund.
NTAGI will review this week’s data of Serum Institute of India’s anti-coronavirus jab Covovax to decide inclusion in the national COVID-19 vaccination programme for inoculating children aged 12 years and above, official said yesterday.
BioNTech said on Wednesday it would extend an ongoing clinical trial programme to produce new vaccines and patterns of administration for better protection against the dominant Omicron coronavirus variant.
Sun Pharma on Wednesday said it has entered into an exclusive patent licensing agreement with Danish-drugmaker Lundbeck to market and distribute its own version of antidepressant medication Vortioxetine in India under the brand name Vortidiftm.
UnitedHealth Group said on Tuesday it would purchase LHC Group for about $5.4 billion in cash, as the largest U.S. health insurer expands its home health services.
Strides Pharma on Tuesday said its founder-promoter Arun Kumar will be assuming executive role as executive chairperson and managing Director effective April 7.
, CDSCO.jpg)
